Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270


Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.

Jeong Y, Xie Y, Xiao G, Behrens C, Girard L, Wistuba II, Minna JD, Mangelsdorf DJ.

PLoS Med. 2010 Dec 14;7(12):e1000378. doi: 10.1371/journal.pmed.1000378.


Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer.

Jeong Y, Xie Y, Lee W, Bookout AL, Girard L, Raso G, Behrens C, Wistuba II, Gadzar AF, Minna JD, Mangelsdorf DJ.

Mol Endocrinol. 2012 Aug;26(8):1443-54. doi: 10.1210/me.2011-1382.


Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients.

Lu Y, Wang L, Liu P, Yang P, You M.

PLoS One. 2012;7(1):e30880. doi: 10.1371/journal.pone.0030880.


Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.

Deng B, Sun Z, Jason W, Yang P.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S701-8. doi: 10.1245/s10434-013-3184-2.


Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.

Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.

J Pathol. 2006 Oct;210(2):192-204.


Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer.

Sasaki H, Tanahashi M, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y.

Lung Cancer. 2002 Apr;36(1):71-6.


Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.

J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134.


Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients.

Xie Y, Xiao G, Coombes KR, Behrens C, Solis LM, Raso G, Girard L, Erickson HS, Roth J, Heymach JV, Moran C, Danenberg K, Minna JD, Wistuba II.

Clin Cancer Res. 2011 Sep 1;17(17):5705-14. doi: 10.1158/1078-0432.CCR-11-0196.


Confirmation of gene expression-based prediction of survival in non-small cell lung cancer.

Guo NL, Wan YW, Tosun K, Lin H, Msiska Z, Flynn DC, Remick SC, Vallyathan V, Dowlati A, Shi X, Castranova V, Beer DG, Qian Y.

Clin Cancer Res. 2008 Dec 15;14(24):8213-20. doi: 10.1158/1078-0432.CCR-08-0095.


The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells.

Pacurari M, Addison JB, Bondalapati N, Wan YW, Luo D, Qian Y, Castranova V, Ivanov AV, Guo NL.

Int J Oncol. 2013 Aug;43(2):548-60. doi: 10.3892/ijo.2013.1963.


Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.

Hayashi M, Tokuchi Y, Hashimoto T, Hayashi S, Nishida K, Ishikawa Y, Nakagawa K, Tsuchiya S, Okumura S, Tsuchiya E.

Anticancer Res. 2001 Jan-Feb;21(1B):535-40.


Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.

Võsa U, Vooder T, Kolde R, Fischer K, Välk K, Tõnisson N, Roosipuu R, Vilo J, Metspalu A, Annilo T.

Genes Chromosomes Cancer. 2011 Oct;50(10):812-22. doi: 10.1002/gcc.20902.


Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer.

Chong IW, Chang MY, Chang HC, Yu YP, Sheu CC, Tsai JR, Hung JY, Chou SH, Tsai MS, Hwang JJ, Lin SR.

Oncol Rep. 2006 Nov;16(5):981-8.


Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.

Zhang D, Jin X, Wang F, Wang S, Deng C, Gao Z, Guo C.

Ann Surg Oncol. 2007 Dec;14(12):3581-92.


Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.

Siegfried JM, Lin Y, Diergaarde B, Lin HM, Dacic S, Pennathur A, Weissfeld JL, Romkes M, Nukui T, Stabile LP.

Neoplasia. 2015 Nov;17(11):817-25. doi: 10.1016/j.neo.2015.11.002.


UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer.

Zhao L, Jiang L, Wang L, He J, Yu H, Sun G, Chen J, Xiu Q, Li B.

J Cancer Res Clin Oncol. 2012 Nov;138(11):1951-61. doi: 10.1007/s00432-012-1275-2.


Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.

Simi L, Venturini G, Malentacchi F, Gelmini S, Andreani M, Janni A, Pastorekova S, Supuran CT, Pazzagli M, Orlando C.

Lung Cancer. 2006 Apr;52(1):59-66.


Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy.

Hou J, Lambers M, den Hamer B, den Bakker MA, Hoogsteden HC, Grosveld F, Hegmans J, Aerts J, Philipsen S.

J Thorac Oncol. 2012 Jan;7(1):105-14. doi: 10.1097/JTO.0b013e3182352a45.


Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007.


Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer.

Rossi G, Papotti M, Barbareschi M, Graziano P, Pelosi G.

J Clin Oncol. 2009 Oct 1;27(28):e141-2; author reply e143-4. doi: 10.1200/JCO.2009.24.0515. No abstract available.

Items per page

Supplemental Content

Support Center